Member Info for bobbust

bid, ask and share price all 15p

some of the delayed trades are buys

given they are doing revolutionary science and on a very limited budget I think what they have done is amazing.
If it was easy everyone would have done it.
And if everyone did it there would be no profit.
Difficult takes time

its not much of a gamble given how many shots on goal Scancell have

I am in profit and have bought since March 2012 and bought at 60p.
But I have picked up loads at 3.68 to 8p

this is one of the few almost perfect shares.
its IP has increased as the SP has fallen. (this IMHO was due to funding issues)
the long (very long ) period has allowed for me to increase my stake over years.
The commercialisation of some of the IP and very meaningful trail results before the cash runs out is a golden time to buy.
Selling now is short sighted, even if there is a near term retrace
Similar view to GF probably
And IP has been proven

given the scancell vaccine works by stimulating T cells could this be given to patients with Covid and would it help?

numerous parties interested in French business so should get a good price for that as well

were they buys? looks like it!!!

if none work its zero
If Modi 1 works £1b plus
Then there is the rest.
All trials and mouse models indicate they have something here.
The IP is worth more than 12p

was the rise today based on the Nottingham paper saying we had started human trials.
And should we not have had this on an RNS?
Or was today just a lot of buying?

IMHO this has been far to cheap.
i keep topping up, should have bought more

for years we have only been a year to 18m away from needing funding.
Now we have a cash for longer and a very good chance of deals and trial results before we run out of cash.
Thats what has changed.
Time to value the IP .

Are you sure on Val.
They consolidated 125 shares to 1.

I wonder if you have any clue as to how shares work?

My guess is this could have been done at close to cost.
First contact, trial of H2 generation and use by AFC.
Significant well respected organisation.
All this points to them getting it at a good price.
Next customer won't get it so cheap

I have bought at 50p and 3.64p not worried about either.
Both will show a profit in the long term.
If I traded shares I would not have as many as I do now.
Each time I sold I would have invested it elsewhere and not necessarily here

What matters is the science, IP and chances of a deal.
It will come good and those that hold will be very happy.
And those that don't can lament on why they didn't buy when so many told them to

Contract award.
Good news

CH had previously stated £5m up front. then there is the £100m to £200m milestone payments.
£5m is a third of what was raised recently which is about 9m cash burn.
one deal could keep the lights on till Modi 1 results.
Remember they can do multiple deals with multiple companies

A further reason is we could sign £1b worth of avidmab deals this year